
Torsade de Pointes/QT Prolongation Associated with Antifungal Triazoles: A Pharmacovigilance Study Based on the U.S. FDA Adverse Event Reporting System(FAERS)
Author(s) -
Zicheng Yu,
Xiaolan Liao
Publication year - 2022
Publication title -
journal of pharmacy and pharmaceutical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.497
H-Index - 78
ISSN - 1482-1826
DOI - 10.18433/jpps32867
Subject(s) - pharmacovigilance , adverse event reporting system , medicine , qt interval , prolongation , adverse effect , antifungal , torsades de pointes , fluconazole , database , computer science , dermatology
Torsade de pointes (TdP)/QT prolongation is a fatal adverse event (AE) when using antifungal triazoles. We aimed to compare the AE signals of TdP/QT prolongation and onset time among different drugs of this kind comprehensively.